Testing effectiveness (Phase 2)Study completedNCT03866967What this trial is testingAnti-PD-1 AK105 in Patients With Metastatic Nasopharyngeal CarcinomaWho this might be right forNasopharyngeal Carcinoma Akeso 130
Early research (Phase 1)Active Not RecruitingNCT03634267What this trial is testingMRI-Guided Brachytherapy in Treating Participants With HPV-Associated Stage IB2-IVA Cervical or Stage II-IVA Vaginal CancerWho this might be right forHuman Papillomavirus-Related CarcinomaHuman Papillomavirus-Related Cervical CarcinomaStage IB2 Cervical Cancer AJCC v8+14 more M.D. Anderson Cancer Center 26
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06814067What this trial is testingPhase II Multi-centered Study of Perioperative Ivonescimab Versus Pembrolizumab Combined with Standard of Care (SOC) in Patients with Resectable, Locally Advanced Head and Neck Squamous Cell CarcinomaWho this might be right forHead and Neck Squamous Cell CarcinomaHead and Neck Squamous Cell Carcinoma HNSCC Fudan University 80
Not applicableEnded earlyNCT00416949What this trial is testingIodine I 131 in Treating Patients With Thyroid CancerWho this might be right forHead and Neck Cancer Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 9
Testing effectiveness (Phase 2)Ended earlyNCT00400205What this trial is testingStudy of Induction Docetaxel, Cisplatin and 5-FluorouracilWho this might be right forSquamous Cell CarcinomaOral Cancer Emory University 14
Not applicableStudy completedNCT00460356What this trial is testingGlycoprotein and Glycan in Tissue and Blood Samples of Patients With Stage IB-IVA Cervical Cancer Undergoing Surgery to Remove Pelvic and Abdominal Lymph NodesWho this might be right forCervical AdenocarcinomaCervical Adenosquamous CarcinomaCervical Small Cell Carcinoma+6 more Gynecologic Oncology Group 159
Testing effectiveness (Phase 2)UnknownNCT01973101What this trial is testingNon-comparative Study of Treatment With Induction Chemotherapy With Cisplatin and Gemcitabine Followed by Chemoradiation or Definitive Chemoradiation in Invasive Locally Advanced Carcinomas of Uterine Cervix.Who this might be right forPatients Diagnosed With Advanced Carcinoma of Uterine Cervix t Instituto do Cancer do Estado de São Paulo 120
Not applicableActive Not RecruitingNCT04574635What this trial is testingHuman Papilloma Virus (HPV) Circulating Tumor DNA (ctDNA) in Cervical CancerWho this might be right forCervical Adenosquamous CarcinomaCervical Squamous Cell Carcinoma, Not Otherwise SpecifiedInfiltrating Cervical Carcinoma+24 more Mayo Clinic 18
Not applicableUnknownNCT02368574What this trial is testingComparison of Class II and Class III Hysterectomy in Early Stage Cervical Cancer Cervical CancerWho this might be right forCervical Cancer Chinese Gynecological Oncology Group 500
Testing effectiveness (Phase 2)Ended earlyNCT01313390What this trial is testingEverolimus and Docetaxel in Treating Patients With Recurrent, Locally Advanced, or Metastatic Head and Neck CancerWho this might be right forHead and Neck Cancer University College, London 4
Not applicableUnknownNCT00983697What this trial is testingFDG-PET/CT in Assessing the Tumor and Planning Neck Surgery in Patients With Newly Diagnosed H&N CancerWho this might be right forHead and Neck Cancer American College of Radiology Imaging Network 292
Testing effectiveness (Phase 2)Study completedNCT02647125What this trial is testingComparing Huachansu Plus Thoracic RT Versus RT Alone For ESCCWho this might be right forEsophageal Squamous Cell Carcinoma Fudan University 126
Testing effectiveness (Phase 2)Looking for participantsNCT05595590What this trial is testingRadiotherapy With Tislelizumab in Patients With Recurrent Head & Neck CancerWho this might be right forHead and Neck Cancer Tianjin Medical University Cancer Institute and Hospital 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT03370276What this trial is testingCetuximab & Nivolumab in Patients With Recurrent/Metastatic Head & Neck Squamous Cell CarcinomaWho this might be right forSquamous Cell Carcinoma of the OropharynxSquamous Cell Carcinoma of the LarynxSquamous Cell Carcinoma of the Oral Cavity+5 more H. Lee Moffitt Cancer Center and Research Institute 95
Testing effectiveness (Phase 2)Looking for participantsNCT06709417What this trial is testingA Phase II Clinical Study of Sintilimab Combined with Chemotherapy Followed by Concurrent Chemoradiotherapy for Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma (ESCC) (NICE-CS)Who this might be right forEsophageal Squamous Cell Carcinoma (ESCC) Shanghai Chest Hospital 52
Testing effectiveness (Phase 2)WithdrawnNCT03818997What this trial is testingCombination of Targeted and Immunotherapy for Advanced Biliary Tract and Esophagogastric Gastric CancerWho this might be right forEsophageal CancerBiliary Tract CancerGastroEsophageal Cancer+1 more European Organisation for Research and Treatment of Cancer - EORTC
Testing effectiveness (Phase 2)Looking for participantsNCT05420948What this trial is testingPembrolizumab in Combination With Chemotherapy for Head and Neck CancerWho this might be right forHead and Neck CancerHead and Neck Squamous Cell CarcinomaHead and Neck Neoplasms+2 more University of Chicago 30
Testing effectiveness (Phase 2)Study completedNCT01522768What this trial is testingAfatinib and Paclitaxel in Patients With Advanced HER2-Positive Trastuzumab-Refractory Advanced Esophagogastric CancerWho this might be right forEsophageal CancerGastric Cancer Memorial Sloan Kettering Cancer Center 42
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07272291What this trial is testingA Phase II Study of Toripalimab Plus Chemotherapy and Low-Dose Radiotherapy for Neoadjuvant Therapy-Refractory Esophageal Squamous Cell CarcinomaWho this might be right forEsophageal Squamous Cell Carcinoma (ESCC) Tianjin Medical University Cancer Institute and Hospital 48
Testing effectiveness (Phase 2)UnknownNCT03972722What this trial is testingStudy of GLS-010 Injection in Patients With Recurrent or Metastatic Cervical CancerWho this might be right forCervical Cancer Guangzhou Gloria Biosciences Co., Ltd. 89